Rating & PT Roundup on Atara Biotherapeutics, Inc. (NASDAQ:ATRA) and Oasmia Pharmaceutical AB (publ) (:OASM)

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) shares have been labeled a top pick by Beta Research as it meets the A+ criteria outlined by the firm.  The stock boasts a consensus analyst “Buy” rating with the consensus recommendation standing at 1.80.  This is according to all covering research brokerage firms taken into consideration by First Call.  The consensus price target of $29.60 also implies significant upside from the current price of $28.25.   

At the time of writing, the stock was trading at $28.25. This represents a change from most recent open price of 27.54%. In terms of performance, year to date, the stock is 56.08%. The monthly stock performance comes in at 93.49%. For the quarter, shares are performing at 90.88%. Weekly performance analysis shows the equity at 52.70%.

In taking a look at technical levels, shares are trading 83.78% away from the 50 day simple moving average and 84.30% away from the 200 day simple moving average. Based on a recent bid, the stock is trading 22.83% away from it’s 52- week high and 139.41% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, Atara Biotherapeutics, Inc.’s RSI stands at 90.70. In looking at volatility levels, the shares saw weekly volatility of 13.41% and 8.87% over the past month.

Stock research firms currently have a positive stance on shares of Oasmia Pharmaceutical AB (publ) (:OASM). Analysts are projecting that the stock will reach $6.00 on a short term (1 year) basis.

The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 2.00. This is based on the research brokerage reports taken into consideration by Thomson Reuters. 

Oasmia Pharmaceutical AB (publ) (:OASM) shares typically trade an average volume of 6.88 and institutions hold 0.41% of the total shares.  


We see here that the stock is 19.82% away from the 20-Day Simple Moving Average.  Their 50-Day Simple Moving Average is a difference of 17.94% from current levels.  Further back, their 200-Day Simple Moving Average is -17.08% difference from today’s price.  Currently, the stock is 4.67% from its 50-Day High and 40.00% from the 50-day low. 

Oasmia Pharmaceutical AB (publ) (:OASM)‘s stock has performed at 27.27%.  Breaking that down further, it has performed 25.32% for the week, 17.92% for the month, 6.67% over the last quarter, 2.66% for the past half-year and -62.64% for this last year. 

Leave a Comment